Welcome
Support Centre
30 October 2014 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   news
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes
statistics

[ Print-friendly version ]
The effect of reiki on pain in women undergoing non-emergency caesarean sections
ISRCTN ISRCTN79265996
DOI 10.1186/ISRCTN79265996
ClinicalTrials.gov identifier
EudraCT number
Public title The effect of reiki on pain in women undergoing non-emergency caesarean sections
Scientific title The effect of reiki on pain in women who will undergo non-emergency caesarean sections and the effect of genetic variation on the use of codeine: a randomised controlled trial
Acronym REPA
Serial number at source REB#-08-030
Study hypothesis Can reiki reduce pain after caesarean section by more than 25%?
Lay summary
Ethics approval St. Michael's Hospital Ethics Review Board approved on the 12th May 2008 (ref: 08-030)
Study design Randomised controlled trial
Countries of recruitment Canada
Disease/condition/study domain Pain levels after caesarean section
Participants - inclusion criteria 1. Informed consent
2. Planned caesarean section
3. Pregnant women aged 18 - 48 years
Participants - exclusion criteria Does not meet with inclusion criteria
Anticipated start date 30/06/2008
Anticipated end date 30/04/2009
Status of trial Completed
Patient information material Not available in web format, please use the contact details below to request a patient information sheet
Target number of participants 80
Interventions 1. Control group: usual care
2. Reiki Group: usual care plus 20 minutes of Remote Reiki

Duration: three days while in the hospital.
Primary outcome measure(s) Visual Analogue Scale for pain in movement, at day 1, day 2 and day 3 (amended as of 10/08/09; initial outcome timepoints were 'after 72 hours in hospital').
Secondary outcome measure(s) 1. Visual Analogue Scale for pain (in rest)
2. Pain medication (codeine consumption/kg)
3. Return time to normal activities

All measured at day 1, day 2 and day 3 (amended as of 10/08/09; initial outcome timepoints were 'after 72 hours in hospital').
Sources of funding Investigator initiated and funded (Canada)
Trial website
Publications
Contact name Dr  Gideon  Koren
  Address Professor of Pediatrics, Pharmacology, Pharmacy, Medicine and Medical Genetics
Clinician-Scientist
The Hospital for Sick Children
Division of Clinical Pharmacology, Rm 8232
555 University Ave
  City/town Toronto
  Zip/Postcode M5G 1X8
  Country Canada
  Tel +1 416 813 1500 ext. 5781
  Email gkoren@sickkids.ca
Sponsor The Hospital for Sick Children (Canada)
  Address c/o Gideon Koren
Professor of Pediatrics, Pharmacology, Pharmacy, Medicine and Medical Genetics
Clinician-Scientist
Division of Clinical Pharmacology, Rm 8232
555 University Ave
  City/town Toronto
  Zip/Postcode M5G 1X8
  Country Canada
  Sponsor website: http://www.sickkids.ca/
Date applied 14/04/2009
Last edited 10/08/2009
Date ISRCTN assigned 27/05/2009
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2014 ISRCTN unless otherwise stated.